The percentages and absolute numbers per tumor weight of tumor-infiltrating CD3+ T, CD3+ CD8+, and CD3+ CD4+ T cells were significantly enhanced after B16-LX/IL-24 immunization (Figure 5G), which suggested that LX/IL-24-modified tumor cells promoted antitumor responses by increased T cell infiltrations in the tumor. The gene discussed is IL24; the disease is neoplasm.